Figure 1.
AUC of markers, (A) miR-650, (B) CA211 and (C) combination model (miR-650 and CA211), to discriminate GC from NC. AUC of markers, (D) miR-650, (E) CA211 and (F) combination model (miR-650 and CA211), to discriminate GC from Pre. AUC, area under the receiver operating characteristic curve; GC, gastric carcinoma; NC, normal control; miR, microRNA; CA211, carbohydrate antigen 211; Pre, precancerous lesions.